Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Irina Vasilyeva Anatolievna (Moscow, Russian Federation), Irina Vasilyeva, Anastasia Samoilova, Svetlana Moiseeva, Natalia Kuzmina, Natalia Musatova. Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus. Eur Respir J 2015; 46: Suppl. 59, 3338

Member's Comments

No comment yet.

Related content which might interest you: Clinical manifestations and efficacy MDR/XDR tuberculosis in patients with different type’s of diabetes mellitus Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015 Impact of diabetes mellitus on drug-resistant tuberculosis treatment outcomes in Georgia – Cohort study Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Effectiveness of lung surgery in MDR TB patients with diabetes mellitus Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016 Impact of diabetes mellitus on clinical parameters and treatment outcomes of diagnosed pulmonary tuberculosis patients Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Plasma concentration of isoniazid and rifampin in new tuberculosis patients with and without diabetes mellitus Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Effect of diabetes mellitus on the Time of mycobacterial clearance from sputum during the treatment of multi-drugs resistant tuberculosis Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014 Addressing the tuberculosis (TB) and diabetes mellitus (DM) co-epidemic among TB patients in Luanda, Angola Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease Year: 2016 Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis in an endemic area Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Tuberculosis and diabetes mellitus: Treatment outcomes using directly observed therapy (DOT) Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Comparison of the clinical manifestations of tuberculosis in patients with different type’s of diabetes mellitus and without it Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016 Factors associated with severity of pulmonary tuberculosis and mortality in TB patients with diabetes mellitus Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014 Tuberculosis with diabetes mellitus: Does delayed sputum conversion always needs MDR evaluation? Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014 Clinical experience of clofazimine in the treatment of MDR-TB Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 MDR-TB treatment outcomes in HIV positive patients Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention Year: 2014 Outcomes among patients with pulmonary TB with diabetes mellitus treated with anti-TB drugs of 1st line Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities Year: 2010 Could side effects of MDR-TB treatment change the outcome of the disease? Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Screening of diabetes mellitus among new cases of tuberculosis Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Treatment interruptions in patients with MDR/XDR-TB: risk factors and impact on treatment outcomes Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016 Failure predictors when treating MDR-TB Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Healing predictors when treating MDR-TB Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015